138 related articles for article (PubMed ID: 12705854)
1. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region.
Hua ZC; Sohn SJ; Kang C; Cado D; Winoto A
Immunity; 2003 Apr; 18(4):513-21. PubMed ID: 12705854
[TBL] [Abstract][Full Text] [Related]
2. A dominant negative Fas-associated death domain protein mutant inhibits proliferation and leads to impaired calcium mobilization in both T-cells and fibroblasts.
Hueber AO; Zörnig M; Bernard AM; Chautan M; Evan G
J Biol Chem; 2000 Apr; 275(14):10453-62. PubMed ID: 10744735
[TBL] [Abstract][Full Text] [Related]
3. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent impairment of T-cell proliferation in FADD dominant-negative transgenic mice.
Zörnig M; Hueber AO; Evan G
Curr Biol; 1998 Apr; 8(8):467-70. PubMed ID: 9550704
[TBL] [Abstract][Full Text] [Related]
5. A tailless fas-FADD death-effector domain chimera is sufficient to execute Fas function in T cells but not B cells of MRL-lpr/lpr mice.
Kabra NH; Cado D; Winoto A
J Immunol; 1999 Mar; 162(5):2766-74. PubMed ID: 10072523
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle effects by C-FADD depend on its C-terminal phosphorylation site.
Alappat EC; Volkland J; Peter ME
J Biol Chem; 2003 Oct; 278(43):41585-8. PubMed ID: 12954630
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities.
Alappat EC; Feig C; Boyerinas B; Volkland J; Samuels M; Murmann AE; Thorburn A; Kidd VJ; Slaughter CA; Osborn SL; Winoto A; Tang WJ; Peter ME
Mol Cell; 2005 Aug; 19(3):321-32. PubMed ID: 16061179
[TBL] [Abstract][Full Text] [Related]
8. The death domain of FADD is essential for embryogenesis, lymphocyte development, and proliferation.
Imtiyaz HZ; Zhou X; Zhang H; Chen D; Hu T; Zhang J
J Biol Chem; 2009 Apr; 284(15):9917-26. PubMed ID: 19203997
[TBL] [Abstract][Full Text] [Related]
9. The solution structure of FADD death domain. Structural basis of death domain interactions of Fas and FADD.
Jeong EJ; Bang S; Lee TH; Park YI; Sim WS; Kim KS
J Biol Chem; 1999 Jun; 274(23):16337-42. PubMed ID: 10347191
[TBL] [Abstract][Full Text] [Related]
10. Constitutive phosphorylation mutation in Fas-associated death domain (FADD) results in early cell cycle defects.
Osborn SL; Sohn SJ; Winoto A
J Biol Chem; 2007 Aug; 282(31):22786-92. PubMed ID: 17553783
[TBL] [Abstract][Full Text] [Related]
11. Casper is a FADD- and caspase-related inducer of apoptosis.
Shu HB; Halpin DR; Goeddel DV
Immunity; 1997 Jun; 6(6):751-63. PubMed ID: 9208847
[TBL] [Abstract][Full Text] [Related]
12. A mouse Fas-associated protein with homology to the human Mort1/FADD protein is essential for Fas-induced apoptosis.
Zhang J; Winoto A
Mol Cell Biol; 1996 Jun; 16(6):2756-63. PubMed ID: 8649383
[TBL] [Abstract][Full Text] [Related]
13. FIST/HIPK3: a Fas/FADD-interacting serine/threonine kinase that induces FADD phosphorylation and inhibits fas-mediated Jun NH(2)-terminal kinase activation.
Rochat-Steiner V; Becker K; Micheau O; Schneider P; Burns K; Tschopp J
J Exp Med; 2000 Oct; 192(8):1165-74. PubMed ID: 11034606
[TBL] [Abstract][Full Text] [Related]
14. A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.
Newton K; Harris AW; Bath ML; Smith KG; Strasser A
EMBO J; 1998 Feb; 17(3):706-18. PubMed ID: 9450996
[TBL] [Abstract][Full Text] [Related]
15. The requirements for Fas-associated death domain signaling in mature T cell activation and survival.
Beisner DR; Chu IH; Arechiga AF; Hedrick SM; Walsh CM
J Immunol; 2003 Jul; 171(1):247-56. PubMed ID: 12817005
[TBL] [Abstract][Full Text] [Related]
16. Protection against Fas-mediated and tumor necrosis factor receptor 1-mediated liver injury by blockade of FADD without loss of nuclear factor-kappaB activation.
Seino K; Setoguchi Y; Ogino T; Kayagaki N; Akiba H; Nakano H; Taniguchi H; Takada Y; Yuzawa K; Todoroki T; Fukuchi Y; Yagita H; Okumura K; Fukao K
Ann Surg; 2001 Nov; 234(5):681-8. PubMed ID: 11685033
[TBL] [Abstract][Full Text] [Related]
17. An apoptosis signaling pathway induced by the death domain of FADD selectively kills normal but not cancerous prostate epithelial cells.
Morgan MJ; Thorburn J; Thomas L; Maxwell T; Brothman AR; Thorburn A
Cell Death Differ; 2001 Jul; 8(7):696-705. PubMed ID: 11464214
[TBL] [Abstract][Full Text] [Related]
18. The three-dimensional solution structure and dynamic properties of the human FADD death domain.
Berglund H; Olerenshaw D; Sankar A; Federwisch M; McDonald NQ; Driscoll PC
J Mol Biol; 2000 Sep; 302(1):171-88. PubMed ID: 10964568
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase.
Scaffidi C; Volkland J; Blomberg I; Hoffmann I; Krammer PH; Peter ME
J Immunol; 2000 Feb; 164(3):1236-42. PubMed ID: 10640736
[TBL] [Abstract][Full Text] [Related]
20. NMR structure and mutagenesis of the FADD (Mort1) death-effector domain.
Eberstadt M; Huang B; Chen Z; Meadows RP; Ng SC; Zheng L; Lenardo MJ; Fesik SW
Nature; 1998 Apr; 392(6679):941-5. PubMed ID: 9582077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
